AMIX Autonomix Medical, Inc. - Common Stock
$0,28
Precio · May 20, 2026
Fundamentales a fecha de Feb 11, 2026
Rango 52S
$0–$3
3% of range
Calificación del Analista
BUY
8 analysts
Precio Objetivo
$2
+627% upside
P/E (TTM)
—
ROE
—
Margen de Beneficio Neto
—
AMIX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.28
Capitalización Bursátil
—
P/E (TTM)
—
BPA (TTM)
—
Ingresos (TTM)
$0
Rendimiento div.
—
ROE
—
Deuda/Capital
—
Rango 52S
$0 – $3
AMIX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$0
2023-03-31
→
2025-03-31
BPA
—
Flujo de caja libre
—
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
AMIX
Mediana de Pares
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
AMIX
Mediana de Pares
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
AMIX
Mediana de Pares
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
AMIX
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
AMIX
Mediana de Pares
AMIX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
8 analistas
- Compra fuerte 3 37,5%
- Compra 4 50,0%
- Mantener 1 12,5%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
1 analistas · 2026-05-17
Mín
$2.00
Máx
$2.00
Objetivo mediano
$2.00
+627,3%
Objetivo medio
$2.00
+627,3%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.16%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de diciembre de 2025 | $-0.36 | $-0.60 | 0.24% |
| 30 de septiembre de 2025 | $-1.38 | $-1.13 | -0.25% |
| 30 de junio de 2025 | $-1.07 | $-1.00 | -0.07% |
| 31 de marzo de 2025 | $-1.81 | $-1.26 | -0.55% |
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| AMIX | — | — | — | — | — | — |
| FEED | $3M | -0.1 | -0.20% | -712.3% | -49.2% | 6.0% |
| AEMD | $58M | -3.4 | — | — | -283.1% | — |
| GCTK | $4M | 0.1 | — | — | -399.4% | — |
| NUWE | $3M | -0.1 | -5.4% | -211.9% | 553.1% | 62.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 12
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | |
| R&D Expense | $5M | $2M | $745.0K | |
| SG&A Expense | $7M | $5M | $1M | |
| Operating Expenses | $12M | $12M | $2M | |
| Operating Income | $-12M | $-12M | $-2M | |
| Interest Income | $354.0K | $127.0K | $0 | |
| Other Non-op | $178.0K | $-3M | $0 | |
| Pretax Income | $-11M | $-15M | $-2M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-11M | $-15M | $-2M | |
| EPS (Basic) | $-6.46 | $-14.82 | $-0.17 | |
| Shares (Basic) | 1,766,425 | 1,040,720 | 12,023,112 |
Balance general 18
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $9M | $9M | $865.0K | |
| Other Current Assets | $473.0K | $783.0K | $0 | |
| Current Assets | $10M | $9M | $865.0K | |
| PP&E (Net) | $21.0K | $16.0K | $0 | |
| Total Assets | $10M | $9M | $865.0K | |
| Accounts Payable | $676.0K | $492.0K | $173.0K | |
| Accrued Liabilities | $1M | $285.0K | $48.0K | |
| Short-term Debt | · | $0 | · | |
| Current Liabilities | $2M | $777.0K | $221.0K | |
| Other Non-current Liabilities | · | · | $0 | |
| Total Liabilities | $2M | $2M | $221.0K | |
| Long-term Debt | · | · | $0 | |
| Common Stock | $2.0K | $1.0K | $12.0K | |
| Paid-in Capital | $58M | $47M | $24M | |
| Retained Earnings | $-50M | $-39M | $-24M | |
| Stockholders' Equity | $8M | $8M | $644.0K | |
| Liabilities + Equity | $10M | $9M | $865.0K | |
| Shares Outstanding | 2,497,033 | 942,575 | 12,336,571 |
Flujo de Efectivo 8
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | · | $81.0K | $0 | |
| Stock-based Comp | · | $618.0K | $0 | |
| Operating Cash Flow | $-8M | $-7M | $-2M | |
| CapEx | · | $19.0K | $0 | |
| Investing Cash Flow | · | $-19.0K | $0 | |
| Stock Issued | · | $3M | $675.0K | |
| Financing Cash Flow | · | $14M | $675.0K | |
| Net Change in Cash | · | $8M | $-1M |
Valoración (TTM) 3
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | |
| Net Income TTM | $-11M | $-15M | · | |
| P / Tangible Book | 0.5 | 149.2 | · |
Estado de resultados 16
| Métrica | Tendencia | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $2M | $2M | $2M | $2M | $1M | $1M | $954.0K | $699.0K | $687.0K | $471.0K | $368.0K | |
| SG&A Expense | $2M | $5M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $793.0K | $503.0K | |
| Operating Expenses | $3M | $8M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $6M | $871.0K | |
| Operating Income | $-3M | $-8M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-6M | $-871.0K | |
| Interest Expense | · | · | · | · | · | · | · | · | $33.0K | · | · | |
| Interest Income | $82.0K | $83.0K | $84.0K | $107.0K | $80.0K | $72.0K | $95.0K | $79.0K | $23.0K | $19.0K | $6.0K | |
| Other Non-op | $82.0K | $83.0K | $84.0K | $60.0K | $35.0K | $29.0K | $54.0K | $-3M | $-189.0K | $-220.0K | $6.0K | |
| Pretax Income | $-3M | $-7M | $-3M | $-3M | $-3M | $-3M | $-3M | $-5M | $-3M | $-6M | $-865.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-3M | $-7M | $-3M | $-11M | $-3M | $-3M | $-3M | $-15M | $-3M | $-6M | $-865.0K | |
| EPS (Basic) | $-0.36 | $-1.38 | $-1.07 | $-0.53 | $-1.46 | $-2.27 | $-2.20 | $-2.90 | $-3.07 | $-8.78 | $-0.07 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | $-0.23 | · | · | |
| Shares (Basic) | 8,955,809 | 5,411,709 | 3,105,156 | -2,545,213 | 1,851,910 | 1,234,305 | 1,225,423 | -13,545,760 | 1,014,036 | 687,840 | 12,884,604 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | 13,799,170 | · | · | |
| EBITDA | $-3M | $-8M | $-3M | · | $-3M | $-3M | $-3M | · | $-3M | · | · |
Balance general 19
| Métrica | Tendencia | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $7M | $9M | $9M | $12M | $5M | $7M | $9M | $1M | · | · | |
| Other Current Assets | $257.0K | $416.0K | $389.0K | $473.0K | $109.0K | $199.0K | $325.0K | $783.0K | $467.0K | · | · | |
| Current Assets | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| PP&E (Net) | $20.0K | $16.0K | $19.0K | $21.0K | $20.0K | $17.0K | $19.0K | $16.0K | $14.0K | · | · | |
| Total Assets | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| Accounts Payable | $714.0K | $842.0K | $815.0K | $676.0K | $232.0K | $574.0K | $287.0K | $492.0K | $663.0K | · | · | |
| Accrued Liabilities | $936.0K | $645.0K | $1M | $1M | $881.0K | $683.0K | $476.0K | $285.0K | $310.0K | · | · | |
| Short-term Debt | · | · | · | · | $1M | · | · | · | · | · | · | |
| Current Liabilities | $2M | $1M | $2M | $2M | $2M | $1M | $763.0K | $777.0K | $973.0K | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | $5M | · | · | |
| Total Liabilities | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $7M | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | $1M | · | · | |
| Total Debt | · | · | · | · | $1M | · | · | · | · | · | · | |
| Common Stock | $11.0K | $6.0K | $4.0K | $2.0K | $2.0K | $1.0K | $19.0K | $1.0K | $14.0K | · | · | |
| Paid-in Capital | $73M | $68M | $61M | $58M | $57M | $48M | $47M | $47M | $28M | · | · | |
| Retained Earnings | $-64M | $-61M | $-54M | $-50M | $-47M | $-44M | $-42M | $-39M | $-34M | · | · | |
| Stockholders' Equity | $9M | $6M | $7M | $8M | $10M | $3M | $5M | $8M | $-6M | · | · | |
| Liabilities + Equity | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| Shares Outstanding | 11,409,344 | 6,194,147 | 4,022,625 | 2,497,033 | 2,462,983 | 1,152,120 | 19,242,081 | 942,575 | 14,430,221 | · | · |
Flujo de Efectivo 11
| Métrica | Tendencia | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.0K | $2.0K | $3.0K | $183.0K | $47.0K | $45.0K | $43.0K | $81.0K | $35.0K | $0 | $0 | |
| Stock-based Comp | $2.0K | $138.0K | $388.0K | $2M | $418.0K | $445.0K | $360.0K | $618.0K | $212.0K | $151.0K | $0 | |
| Other Non-cash | · | · | $342.0K | · | · | · | $444.0K | · | · | · | · | |
| Operating Cash Flow | $-3M | $-4M | $-3M | $-8M | $-2M | $-2M | $-2M | $-7M | $-3M | $-1M | $-661.0K | |
| CapEx | $7.0K | $0 | $0 | $14.0K | $5.0K | $0 | $5.0K | $19.0K | $16.0K | $0 | $0 | |
| Investing Cash Flow | $-7.0K | $0 | $0 | $-14.0K | $-5.0K | $0 | $-5.0K | $-19.0K | $-16.0K | $0 | $0 | |
| Stock Issued | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $3M | |
| Net Stock Activity | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $5M | $3M | $2M | $9M | $9M | $0 | $0 | $14M | $2M | $350.0K | $3M | |
| Net Change in Cash | $2M | $-1M | $-547.0K | $528.0K | $7M | $-2M | $-2M | $8M | $-927.0K | $-794.0K | $2M | |
| Free Cash Flow | · | · | $-3M | · | · | · | $-2M | · | · | · | · |
Rentabilidad 3
| Métrica | Tendencia | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -29.4% | -112.0% | -41.5% | · | -39.4% | -104.5% | -76.1% | · | -344.2% | · | · | |
| ROE | -35.7% | -157.3% | -54.2% | · | -131.9% | -185.4% | -102.1% | · | 111.3% | · | · | |
| ROIC | -39.1% | -116.9% | -48.6% | · | -25.3% | -93.7% | -52.0% | · | 52.3% | · | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | 5.3 | 4.6 | · | 5.3 | 4.3 | 9.3 | · | 1.7 | · | · | |
| Quick Ratio | 6.0 | 5.0 | 4.4 | · | 5.3 | 4.1 | 8.8 | · | 1.3 | · | · | |
| Debt / Equity | · | · | · | · | 0.1 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -88.6 | · | · |
Eficiencia 1
| Métrica | Tendencia | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Valoración (TTM) 9
| Métrica | Tendencia | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | |
| Net Income TTM | $-25M | $-25M | $-20M | · | $-24M | $-24M | $-27M | · | $-11M | · | · | |
| Market Cap | $6M | $7M | $6M | · | $9M | $14M | $369M | · | · | · | · | |
| Enterprise Value | · | · | · | · | $-1M | · | · | · | · | · | · | |
| P/B | 0.7 | 1.0 | 0.9 | · | 1.0 | 4.6 | 69.9 | · | · | · | · | |
| P / Tangible Book | 0.7 | 1.0 | 0.9 | · | 1.0 | 4.6 | 69.9 | · | · | · | · | |
| P / Cash Flow | · | · | -2.4 | · | · | · | -199.5 | · | · | · | · | |
| P / FCF | · | · | -2.4 | · | · | · | -198.9 | · | · | · | · | |
| EV / EBITDA | · | · | · | · | 0.5 | · | · | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-03-31 | 2024-03-31 | 2023-03-31 | |
|---|---|---|---|
| Ingresos | $0 | $0 | $0 |
| Beneficio neto | $-11M | $-15M | $-2M |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.